DOI: 10.1055/s-00029025

Journal of Pediatric Epilepsy

References

French JA, Lawson JA, Yapici Z. et al.
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.

Lancet 2016;
388 (10056): 2153-2163

Download Bibliographical Data

Access:
Access: